top of page
Tom Finn.png
Tom Finn
Genome Alberta

Tom joined the Genome Alberta team in September 2022. In his role, he supports the Alberta research community in the development of research proposals, promoting the use of new genomics technologies and applications to solve real-world, pressing issues. Tom helps to identify key strategic partnerships among leading academics and researchers across a variety of sectors including health, agriculture, forestry, energy and the environment.
Before joining Genome Alberta, Tom was a post-doctoral fellow in the Immunology Microbiology and Infectious Diseases Department of the Cumming School of Medicine at the University of Calgary. His research focused on understanding the evolution of the antimicrobial-resistant pandemic E. coli clone ST131. Prior to this, he was a post-doctoral researcher in the Biochemistry Department of Otago University, New Zealand, where he investigated the use of collateral sensitivity as a means of combating the evolution of superresistant microbes.
Tom received his PhD in Evolutionary Genetics from Massey University, New Zealand and a BSc from University College Cork, Ireland.

bottom of page